Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.53, read 2026-10-27
Ethical screen not yet scored
Price64.93 USD
Fair value104.91
Ethical score70.0/100
Our investment reviews on this name
2026-10-11Read Markdown66.21-1.9% to today ✓Accumulation gives way to Markdown after an 8% slide in 3 weeks
2026-09-21Read Accumulation71.88-9.7% to today Distribution gives way to Accumulation with volume flow in agreement
2026-07-02Read Distribution71.85-9.6% to today ✓First review on file: Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The Andersons, Inc. holds its Markdown at $64.93. The statistical read favours the sellers, held for 10 days.
As held on the ledger · 2026-10-23
Phase
Markdown · caution
Quantitative state
The statistical read favours the sellers, held for 10 days
Price at the screen
$64.93
Valuation
12.40 trailing · 10.04 forward price to earnings
Values screen
Not scored· score 70.0
Beta
0.66
The Workings
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
Excluded
Below 33%
Interest-bearing debt is of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
Excluded
Below 33%
Interest-bearing cash and securities are of assets, above the one-third limit.
Fail
Receivables
Excluded
Below 49%
Money owed to the company is of assets, above the 49% limit.
Fail
Revenue purity
0.07%
Below 5%
Only 0.1% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
The Read, in Plain English
The Andersons, clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. A 63.3% margin of safety to the base estimate.
The Street's Range
80.00Street low90.00Street high64.93Price
Third-party analyst targets.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
Picture a Midwest elevator buying corn one week and selling it the next while prices swing on weather reports and export orders. The Andersons sits in that exact spot, moving commodities and renewable fuels through an agribusiness segment that has delivered almost no revenue growth and just a one percent profit margin. A forward multiple of twelve times earnings looks attractive on paper, yet the business earns only a ten percent return on equity with an unknown competitive edge, so the opportunity rating stays at none.
Analysts see upside to eighty dollars and the shares trade below our internal fair value, but low growth and slim margins point to a classic cyclical setup rather than a durable bargain. Revenue has already slipped one percent and the company operates in markets where peak earnings often coincide with the lowest multiples. An ethical screen is passed, yet that alone does not create an investment case when the underlying economics remain this tight.
Risk sits in commodity price swings, weather events and thin buffers that can turn modest profits into losses quickly. The low multiple is a warning, not a signal. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
ANDE trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-28Markdown$64.24+0.0%Entry 13
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 110%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (3 analysts) rates it strong buy, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Markdown$64.24+0.0%Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 110%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (3 analysts) rates it strong buy, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Markdown$64.24-2.2%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 110%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (3 analysts) rates it strong buy, with a mean price target of $80.
2026-10-18Markdown$65.68-0.8%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 110%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (3 analysts) rates it strong buy, with a mean price target of $80.
2026-10-11Markdown · changed$66.21+0.0%Entry 9
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 110%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (3 analysts) rates it strong buy, with a mean price target of $80.
2026-10-02Accumulation$66.21-7.9%Entry 8
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 7.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 110%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (3 analysts) rates it strong buy, with a mean price target of $80.
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 110%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (3 analysts) rates it strong buy, with a mean price target of $80.
2026-08-21Distribution$67.95-14.2%Entry 6
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 14.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 110%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (3 analysts) rates it strong buy, with a mean price target of $80.
2026-07-21Distribution$79.24+10.3%Entry 5
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 10.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 110%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (3 analysts) rates it strong buy, with a mean price target of $80.
2026-07-18Distribution$71.85+0.0%Entry 4
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 110%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (3 analysts) rates it strong buy, with a mean price target of $80.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
